Monoclonal antibodies were raised against homogeneous Ro and La antigens, two proteins associated with Ro and La ribonucleoproteins (RNPs). The specificity of the monoclonal antibodies was proven by immunoblot analysis and by immunoprecipitation. The anti-Ro antibody reacted with a Mr 95,000 protein in a mouse lymphoma cell extract and with a Mr 60,000 polypeptide in extracts from human spleen. The anti-La antibody recognized a Mr 50,000 polypeptide in the mouse L5178y cell extract. (3,4). RNA analysis revealed that Ro small cytoplasmic RNPs (scRNPs) carry the La as well as the Ro determinants and, consequently, were a subclass of La RNPs (5). Based on immunoprecipitation studies, the molecular weight of the Ro antigen(s) was determined to be 94,000 (90,000) (6), while analysis by immunoblotting revealed a Mr of 57,000 (7). Comparative experiments using the techniques of counterimmunoelectrophoresis and immunoblotting led to the assumption that the Ro antigenic determinant is labile when exposed to NaDodSO4 (8 (Junction City, OR).Preparation of the Anti-Ro and Anti-La mAbs. Homogeneous Ro and La antigens were prepared from L5178y mouse lymphoma cells (38). Briefly, crude cell extracts were enriched for Ro and La antigens by ammonium sulfate fractionation (45-80% saturation), ribonuclease A treatment, and Sephadex G-150 gel filtration. This extract was further purified by immunoaffinity column chromatography with monospecific antibodies against the Ro and La antigens according to the procedure described below for the application of mAbs. The antisera were obtained from patients with autoimmune disorders. The homogeneity of the antigen preparations was proven by NaDodSO4/gel electrophoresis, and their specificities, by immunoblotting (12) with standardized reference antisera (anti-Ro and anti-La; Centers for Disease Control, Atlanta). General procedures for preparation of mAbs (12,13)